Nalaganje...

Sweet’s syndrome after adalimumab therapy for refractory relapsing polychondritis

Relapsing polychondritis and Sweet’s syndrome are rare systemic inflammatory conditions. The authors present a patient who developed Sweet’s syndrome 1 week after adalimumab therapy for refractory relapsing polychondritis. Coexistent relapsing polychondritis and Sweet’s syndrome is rare, however, is...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Keidel, Sarah, McColl, Aubretia, Edmonds, Sally
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2011
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3246157/
https://ncbi.nlm.nih.gov/pubmed/22670004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr.10.2011.4935
Oznake: Označite
Brez oznak, prvi označite!